235 related articles for article (PubMed ID: 19116990)
1. Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia.
Harada K; Sato Y; Ikeda H; Isse K; Ozaki S; Enomae M; Ohama K; Katayanagi K; Kurumaya H; Matsui A; Nakanuma Y
J Pathol; 2009 Apr; 217(5):654-64. PubMed ID: 19116990
[TBL] [Abstract][Full Text] [Related]
2. Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.
Harada K
Pediatr Surg Int; 2017 Dec; 33(12):1243-1248. PubMed ID: 29039048
[TBL] [Abstract][Full Text] [Related]
3. Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia.
Harada K; Sato Y; Itatsu K; Isse K; Ikeda H; Yasoshima M; Zen Y; Matsui A; Nakanuma Y
Hepatology; 2007 Oct; 46(4):1146-54. PubMed ID: 17661372
[TBL] [Abstract][Full Text] [Related]
4. Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia.
Harada K; Sato Y; Isse K; Ikeda H; Nakanuma Y
Liver Int; 2008 May; 28(5):614-21. PubMed ID: 18433391
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.
Okamura A; Harada K; Nio M; Nakanuma Y
Clin Exp Immunol; 2013 Aug; 173(2):268-75. PubMed ID: 23607494
[TBL] [Abstract][Full Text] [Related]
6. Biliary innate immunity in the pathogenesis of biliary diseases.
Harada K; Nakanuma Y
Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
[TBL] [Abstract][Full Text] [Related]
7. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia.
Xiao Y; Zhou Y; Chen Y; Zhou K; Wen J; Wang Y; Wang J; Cai W
Pediatr Res; 2015 Feb; 77(2):310-5. PubMed ID: 25406900
[TBL] [Abstract][Full Text] [Related]
8. LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells.
Zhao L; Yang R; Cheng L; Wang M; Jiang Y; Wang S
J Surg Res; 2011 Dec; 171(2):819-25. PubMed ID: 20691985
[TBL] [Abstract][Full Text] [Related]
9. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
Strutz F; Zeisberg M; Ziyadeh FN; Yang CQ; Kalluri R; Müller GA; Neilson EG
Kidney Int; 2002 May; 61(5):1714-28. PubMed ID: 11967021
[TBL] [Abstract][Full Text] [Related]
10. Effect of miR-29c and miR-129-5p on epithelial-mesenchymal transition in experimental biliary atresia mouse models.
Wang JY; Li ZH; Ye M; Feng Q; Chen ZM; Ye XS; Wu ZG; Wang B; Liu L; Yao J
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706677
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasis.
Sung R; Lee SH; Ji M; Han JH; Kang MH; Kim JH; Choi JW; Kim YC; Park SM
J Gastroenterol Hepatol; 2014 Feb; 29(2):395-402. PubMed ID: 23927024
[TBL] [Abstract][Full Text] [Related]
12. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
[TBL] [Abstract][Full Text] [Related]
13. Biliary innate immunity: function and modulation.
Harada K; Nakanuma Y
Mediators Inflamm; 2010; 2010():. PubMed ID: 20798866
[TBL] [Abstract][Full Text] [Related]
14. TWEAK enhances TGF-β-induced epithelial-mesenchymal transition in human bronchial epithelial cells.
Itoigawa Y; Harada N; Harada S; Katsura Y; Makino F; Ito J; Nurwidya F; Kato M; Takahashi F; Atsuta R; Takahashi K
Respir Res; 2015 Apr; 16(1):48. PubMed ID: 25890309
[TBL] [Abstract][Full Text] [Related]
15. Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia.
Deng YH; Pu CL; Li YC; Zhu J; Xiang C; Zhang MM; Guo CB
Dig Dis Sci; 2011 Mar; 56(3):731-40. PubMed ID: 20725787
[TBL] [Abstract][Full Text] [Related]
16. Autophagy and senescence in fibrosing cholangiopathies.
Nakanuma Y; Sasaki M; Harada K
J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
[TBL] [Abstract][Full Text] [Related]
17. Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia.
Okamura A; Harada K; Nio M; Nakanuma Y
J Clin Pathol; 2013 Feb; 66(2):99-108. PubMed ID: 23162109
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic plasticity of the ovarian surface epithelium: TGF-beta 1 induction of epithelial to mesenchymal transition (EMT) in vitro.
Zhu Y; Nilsson M; Sundfeldt K
Endocrinology; 2010 Nov; 151(11):5497-505. PubMed ID: 20844000
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease.
Rygiel KA; Robertson H; Marshall HL; Pekalski M; Zhao L; Booth TA; Jones DE; Burt AD; Kirby JA
Lab Invest; 2008 Feb; 88(2):112-23. PubMed ID: 18059363
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells.
Kim JH; Jang YS; Eom KS; Hwang YI; Kang HR; Jang SH; Kim CH; Park YB; Lee MG; Hyun IG; Jung KS; Kim DG
J Korean Med Sci; 2007 Oct; 22(5):898-904. PubMed ID: 17982242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
